Biomarker discovery and validation for gastrointestinal tumors: A comprehensive review of colorectal, gastric, and liver cancers
Author:
- 16 February 2024
- journal article
- review article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 255, 155216
Abstract
No abstract availableKeywords
This publication has 154 references indexed in Scilit:
- Evaluation of Individual and Combined Applications of Serum Biomarkers for Diagnosis of Hepatocellular Carcinoma: A Meta-AnalysisInternational Journal of Molecular Sciences, 2013
- Cancer Development, Progression, and Therapy: An Epigenetic OverviewInternational Journal of Molecular Sciences, 2013
- Role of the Helicobacter pylori‐Induced inflammatory response in the development of gastric cancerJournal of Cellular Biochemistry, 2012
- A combined oncogenic pathway signature of BRAF , KRAS and PI3KCA mutation improves colorectal cancer classification and cetuximab treatment predictionGut, 2012
- A Comprehensive Survey of Ras Mutations in CancerCancer Research, 2012
- Cancer gene discovery in hepatocellular carcinomaJournal of Hepatology, 2010
- Prognostic and predictive factors in colorectal cancer: Kirsten Ras in CRC (RASCAL) and TP53CRC collaborative studiesAnnals of Oncology, 2005
- CDX2, a Highly Sensitive and Specific Marker of Adenocarcinomas of Intestinal OriginAmerican Journal of Surgical Pathology, 2003
- Identification of FAP Locus Genes from Chromosome 5q21Science, 1991
- A genetic model for colorectal tumorigenesisCell, 1990